Fig. 6. Schematic diagram of the novel ferroptosis-targeted therapeutic strategy by combination of melatonin and zileuton. The scheme shows that the combination of melatonin and zileuton increases cell survival by inhibiting the ferroptosis signaling pathway in renal injury.
© Biomolecules & Therapeutics
